The product license allows finished products to be marketed with claims relevant to liver, cardiovascular, and gut health, as well as blood glucose and stress.
Our most-viewed stories in January included Amazon's warning letter from FDA, economically-motivated adulteration in botanicals, and supplement trends to watch.
The first-of-its-kind state bill, which bans the sale of “weight loss” and “muscle building” supplements to minors, is slated to go into effect in April 2024.
The guidance, issued this year is a departure from common marketing practice of dietary supplements and food, and misrepresents the state of the law, CRN said.
The prebiotic fiber received approval for eight claims in total, and unrestricted use in dietary supplements regulated by the Therapeutic Goods Administration.
If a claim describes the substantiated role a nutrient or dietary ingredient plays in the body, plaintiffs cannot survive a motion for summary judgment.
By Todd Harrison, Partner; Richard Starr, Associate; and Olisa Onyiuke, Associate, Venable06.02.22
Plaintiffs are monitoring whether a company abides by all relevant FDA regulations, so it’s important to understand requirements and confirm disclaimers.
By Todd Harrison, Partner; Kristen Klesh, Counsel; Olisa Onyiuke, Associate; and Melanie English, Associate Venable04.14.22
The FDA ruling on claims that cranberry can reduce UTI incidence will be used by the company as a launchpad for delivery system innovation, the supplier said.
Following a review of the evidence, FDA now supports three types of claims on the research, which it still considers to be “inconsistent and inconclusive.”